130 related articles for article (PubMed ID: 20849922)
1. Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration.
Li T; Hou Y; Yan CX; Chen T; Zhao Y; Li SB
Neurosci Lett; 2010 Nov; 485(3):256-60. PubMed ID: 20849922
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 receptor-regulated NR2B subunits of N-methyl-d-aspartate receptors in the nucleus accumbens involves in morphine-induced locomotor activity.
Liu XS; Hou Y; Yan TL; Guo YY; Han W; Guan FL; Chen T; Li T
CNS Neurosci Ther; 2014 Sep; 20(9):823-9. PubMed ID: 24797707
[TBL] [Abstract][Full Text] [Related]
4. Influence of morphine and dopamine receptor sensitization on locomotor activity in mice.
Heidari P; Sahebgharani M; Riazi G; Zarrindast MR
Pharmacology; 2006; 78(4):185-92. PubMed ID: 17063042
[TBL] [Abstract][Full Text] [Related]
5. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
Zarrindast MR; Asgari-Afshar A; Sahebgharani M
Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
[TBL] [Abstract][Full Text] [Related]
6. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
7. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
8. [The role of dopamine D3 receptor in the amphetamine-induced conditioned place preference in mice].
Zhu JY; Chen LP; Li L; Zheng HB; Chen T
Fa Yi Xue Za Zhi; 2007 Dec; 23(6):428-30. PubMed ID: 18402112
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
Sheppard B; Lehmann J; Cope ZA; Brown RW
Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
[TBL] [Abstract][Full Text] [Related]
10. Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor.
Yarkov AV; Der TC; Joyce JN
Eur J Pharmacol; 2010 Feb; 627(1-3):167-72. PubMed ID: 19900441
[TBL] [Abstract][Full Text] [Related]
11. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice.
Karper PE; De la Rosa H; Newman ER; Krall CM; Nazarian A; McDougall SA; Crawford CA
Psychopharmacology (Berl); 2002 Feb; 159(4):407-14. PubMed ID: 11823893
[TBL] [Abstract][Full Text] [Related]
12. Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.
Lv Y; Hu RR; Jing M; Zhao TY; Wu N; Song R; Li J; Hu G
Acta Pharmacol Sin; 2019 May; 40(5):583-588. PubMed ID: 30224637
[TBL] [Abstract][Full Text] [Related]
13. Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors.
Lo PS; Wu CY; Sue HZ; Chen HH
Toxicology; 2009 Nov; 265(1-2):34-40. PubMed ID: 19765629
[TBL] [Abstract][Full Text] [Related]
14. Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala.
Sepehrizadeh Z; Sahebgharani M; Ahmadi S; Shapourabadi MB; Bozchlou SH; Zarrindast MR
Pharmacology; 2008; 81(4):333-43. PubMed ID: 18391508
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion.
Pritchard LM; Newman AH; McNamara RK; Logue AD; Taylor B; Welge JA; Xu M; Zhang J; Richtand NM
Pharmacol Biochem Behav; 2007 Apr; 86(4):718-26. PubMed ID: 17408730
[TBL] [Abstract][Full Text] [Related]
16. Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine.
Johnson PI; Napier TC
Synapse; 2000 Oct; 38(1):61-70. PubMed ID: 10941141
[TBL] [Abstract][Full Text] [Related]
17. A new buprenorphine analogy, thenorphine, inhibits morphine-induced behavioral sensitization in mice.
Zhao WL; Gong ZH; Liang JH
Acta Pharmacol Sin; 2004 Nov; 25(11):1413-8. PubMed ID: 15525461
[TBL] [Abstract][Full Text] [Related]
18. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
Biala G; Staniak N
Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
[TBL] [Abstract][Full Text] [Related]
19. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice.
Cook CD; Beardsley PM
Pharmacol Biochem Behav; 2003 May; 75(2):363-71. PubMed ID: 12873628
[TBL] [Abstract][Full Text] [Related]
20. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization.
Leite-Morris KA; Fukudome EY; Shoeb MH; Kaplan GB
J Pharmacol Exp Ther; 2004 Feb; 308(2):667-78. PubMed ID: 14610238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
